Assessment of lymphoma therapy using 18F-FDG PET

Journal of Nuclear Medicine

Volumn 43, Issue 8, 2002, Pages 1028-1030

  Lowe, Val J ^a   Wiseman, Gregory A ^a  

^a MAYO CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; BLEOMYCIN; CISPLATIN; CYCLOPHOSPHAMIDE; DACARBAZINE; DAUNORUBICIN; DEXAMETHASONE; DOXORUBICIN; ETOPOSIDE; FLUORODEOXYGLUCOSE F 18; IFOSFAMIDE; PREDNISONE; VINBLASTINE; VINCRISTINE SULFATE;

ADULT; AGED; BONE MARROW TRANSPLANTATION; CANCER COMBINATION CHEMOTHERAPY; CLINICAL ARTICLE; COMPUTER ASSISTED TOMOGRAPHY; DIAGNOSTIC ACCURACY; DIAGNOSTIC IMAGING; FEMALE; HUMAN; LYMPHOMA; MALE; NONHODGKIN LYMPHOMA; NOTE; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; PROGNOSIS; SCINTILLATION CAMERA; TREATMENT OUTCOME;

ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; FLUORODEOXYGLUCOSE F18; HODGKIN DISEASE; HUMANS; LYMPHOMA, NON-HODGKIN; PROGNOSIS; RADIOPHARMACEUTICALS; TOMOGRAPHY, EMISSION-COMPUTED;

EID: 0036322081     PISSN: 01615505     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Note

References (18)

1. Gallium-67 imaging: A predictor of residual tumor viability and clinical outcome in patients with diffuse large-cell lymphoma
2. Lymphoma: Predictive value of Ga-67 scintigraphy after treatment
3. 67Ga scintigraphy
4. The role of Ga-67 scintigraphy in evaluating the results of therapy of lymphoma patients
5. 18F-fluorodeoxyglucose for posttreatment evaluation in Hodgkin's disease and non-Hodgkin's lymphoma has higher diagnostic and prognostic value than classical computed tomography scan imaging
6. Single-photon emission computed tomography gallium imaging versus computed tomography: Predictive value in patients undergoing high-dose chemotherapy and autologous stem-cell transplantation for non-Hodgkin's lymphoma
7. Early restaging gallium scans predict outcome in poorprognosis patients with aggressive non-Hodgkin's lymphoma treated with high-dose CHOP chemotherapy
8. Gallium-67 scintigraphy evaluation of therapy in non-Hodgkin's lymphoma
9. Results of MIME salvage regimen for recurrent or refractory lymphoma
10. Treatment of relapsed non-Hodgkin's lymphomas with dexamethasone, high-dose cytarabine, and cisplatin before marrow transplantation
11. Effective salvage therapy for lymphoma with cisplatin in combination with high-dose Ara-C and dexamethasone (DHAP)
12. Autologous stem cell transplantation in aggressive non-Hodgkin's lymphoma
13. 18FDG-PET following treatment as valid predictor for disease-free survival in Hodgkin's lymphoma
14. PET predicts prognosis after 1 cycle of chemotherapy in aggressive lymphoma and Hodgkin's disease
15. 18F-FDG uptake after a few cycles of polychemotherapy is predictive of treatment failure in non-Hodgkin's lymphoma
16. 18F]FDG-PET a valid alternative to conventional diagnostic methods?
17. Positron emission tomography in non-Hodgkin's lymphoma: Assessment of chemotherapy with fluorodeoxyglucose
18. Oncologic diagnosis with 2-[fluorine-18]fluoro-2-deoxy-D-glucose imaging: Dual-head coincidence gamma camera versus positron emission tomographic scanner